The Screening and Evaluating of Chitosan/β-Cyclodextrin Nanoparticles for Effective Delivery Mitoxantrone Hydrochloride

Yiwen Wang,Fei Qin,Mei Lu,Li Gao,Xin Yao
DOI: https://doi.org/10.1134/s0965545x17030191
2017-01-01
Polymer Science Series A
Abstract:The complex of chitosan and β-cyclodextrin (CS-CMβ-CD) has been widely used as drug carrier because it binds the advantages of GCH and β-CDs. But further investigation is still needed to improve their delivery performance before CS-β-CD derivatives can be used as clinical cancer-drug carriers. The aim of the study is to screen suitable carriers of the deviants of chitosan and β-cyclodextrin by evaluating the delivery performance of several carriers towards anticancer drugs. Three kinds of GCS n -CM m β-CD polymers made of different amount of glycol chitosan (GCS) and carboxymethyl-β-cyclodextrin (CMβ-CD) were synthesized and GCS7.5-CM3-7β-CD was chosen to deliver the drugs due to its better properties. GCS7.5-CM3-7β-CD polymers have better cell adhesion performance than GCS, help to directional drug delivery. Then, mitoxantrone hydrochloride (MAH) was used as a model drug to evaluate the loading and releasing properties of GCS7.5-CM3-7β-CD polymers. GCS7.5-CM3-7β-CD polymers could encapsulate MAH with higher loading efficiency and provide pH sensitive MAH release. The amount of MAH released in acidic medium (pH 5.0) was greater than that in weakly basic medium (pH 7.4). The MAH-loaded nanoparticles shows similar inhibition ability as free MAH to HCT116 cell lines, indicate that MAH can be release from the carrier and kill the cancer cells. In addition, the blank GCS7.5-CM3-7β-CD nanoparticles show good biocompatibility to the cell. That is to say, GCS7.5-CM3-7β-CD polymers not only have the ability to targeting drug delivery but also can realize pH sensitive release, which make them perspective in cancer pharmaceutical application.
What problem does this paper attempt to address?